NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/06/2024
Back to search
Official data from USPTO
THE LOOK OF 3
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
08/06/2024
Classification
Registered
Trademark type
Combined
Nice classes
44
Filing date
05/18/2021
Registration date
08/06/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/06/2024
Last transaction
08/06/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/21/2021
First use in commerce
12/21/2021
Drawing code
5
Owner type
03
Owner location
North Chicago, IL, US
Examiner
DONEGAN, DANIEL
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the words "THE","LOOK" and "OF" stacked one on top of the other with the word "LOOK" larger than the words "THE" and "OF". The number "3" is the full height of and to the right of the three stacked words. The word "LOOK" and the bottom half of the numeral "3" are bold. The top half of the numeral "3" is comprised of three parallel lines.
Holders and representatives
Holders
Allergan, Inc.
Allergan, Inc.
Representatives
Allergan, Inc.
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Providing information to patients via a website relating to cosmetic skin care treatments using botulinum toxin injections
Publications
History of USPTO decisions and trademark events.
32 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/06/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/01/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/26/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/26/2024
ALIE
ASSIGNED TO LIE
06/26/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/23/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/22/2024
GNRT
NON-FINAL ACTION E-MAILED
03/22/2024
CNRT
SU - NON-FINAL ACTION - WRITTEN
03/22/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/07/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/07/2023
IUAF
USE AMENDMENT FILED
07/25/2023
EISU
TEAS STATEMENT OF USE RECEIVED
07/25/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/17/2023
EX1G
SOU EXTENSION 1 GRANTED
02/15/2023
EXT1
SOU EXTENSION 1 FILED
02/15/2023
EEXT
SOU TEAS EXTENSION RECEIVED
02/15/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/16/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/21/2022
PUBO
PUBLISHED FOR OPPOSITION
06/21/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/01/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/16/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/13/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/13/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/13/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/24/2021
GNRT
NON-FINAL ACTION E-MAILED
11/24/2021
CNRT
NON-FINAL ACTION WRITTEN
11/24/2021
DOCK
ASSIGNED TO EXAMINER
11/24/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/16/2021
Continuous trademark protection
Get notified about every new filing that threatens THE LOOK OF 3 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.